ASHG 2024
We're going to be
at ASHG 2024

November 5–9, 2024 | Colorado Convention Center | Denver, CO

 

ASHG 2024
We're going to be
at ASHG 2024

November 5–9, 2024
Colorado Convention Center
Denver, CO

Standard BioToolsTM is thrilled to be attending the American Society of Human Genetics 2024 Annual Meeting from November 5–9 in Denver, CO.

The conference provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics and genomics and brings together leading experts and scientists from around the world to present research at symposium, plenary, platform and poster sessions.

Denver, CO

  • November 5–9
  • Booth 145
  • Denver, CO

Learn more

Industry Education Sessions

Pharmacogenomics for AMP Tier 1 target coverage using Novel Nanofluidic qPCR Methodology

This industry education session will focus on cutting-edge advancements in pharmacogenomics (PGx), emphasizing the utilization of nanoscale genomics to achieve comprehensive coverage of Association for Molecular Pathology (AMP) Tier 1 targets across a range of therapeutic areas. Naveen Ramalingam, PhD, Senior Director of R&D at Standard BioTools, will present on the revolutionary application of nanofluidic qPCR technology, while Katherine Aitchison, BM BCh, PhD, FRCPsych, Professor (Departments of Psychiatry & Medical Genetics, College of Health Sciences, University of Alberta), will present preliminary results from a beta testing site, including target coverage implications for neuropsychiatric disorders.


Full coverage of Tier 1 Variants for Pharmacogenomics Studies

Wednesday, November 6 | 2:30 – 4:30pm | Poster #7022W
Presenter: Naveen Ramalingam

This poster presents a robust, automated qPCR-based workflow that successfully integrates SNP and CNV analyses, ensuring full coverage of Tier 1 variants recommended by the AMP. This approach streamlines genetic testing and enhances the accuracy and applicability of PGx testing in clinical settings, potentially improving patient outcomes through more precise and personalized medicine.

→ SPEAKERS:

Naveen Ramalingam, PhD
Senior Director of Assay Development and Single-Cell Omics R&D,
Standard BioTools


Katherine Aitchison,
BM BCh, PhD, FRCPsych

Professor, Departments of Psychiatry & Medical Genetics, College of Health Sciences, University of Alberta

SAVE YOUR SEAT

The Biomark™ X9 System for High-Throughput Genomics

This system allows you to get big answers with micro-sized technology. This versatile benchtop platform delivers thousands of nanoliter-scale reactions in a single run, providing speed, scalability and walk-away automation that enable efficient genomic testing and the investigation of the relationship between a specific gene profile and a novel drug. Help facilitate PGx studies at 2x the speed with a single high-throughput workflow that consolidates multiple assays into one experiment.

Learn more about the Biomark X9 System

Learn more about PGx and microfluidics

 

The Biomark X9 Instrument from Standard BioTools

Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.